• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Understanding of How Cells Turn Cancerous Advances at UCR

Snowy Owl

Retired in 2010, In Memoriam
Understanding of How Cells Turn Cancerous Advances at UCR
http://www.physorg.com/news76171887.html

A research team, led by Professor of Xuan Liu, showed how proteins in the nucleus of cells, PTEN and p53, interact to prevent a cell that has suffered damage from mutating into a cancerous tumor.

Liu, who has been studying the workings of tumor suppressor proteins for the past decade, says the latest discovery by researchers in her laboratory provides an exciting new link in understanding how these proteins work together to regulate how or whether the cell replicates or dies.

“Our previous paper showed that these two proteins (PTEN and p53) work together to regulate the cell,” she said. “This paper begins to show how the two work together.”

Liu published her research findings in a featured article titled Mechanistic insights into maintenance of high p53 acetylation by PTEN, in the Aug. 18 issue of Molecular Cell. Co-authors include UCR colleagues Andrew G. Li, Landon G. Piluso Xin Cai and Gang Wei; with William R. Sellers in the Department of Medical Oncology, Dana Ferber Cancer Institute of Harvard University in Boston.

They found that when a cell’s DNA becomes damaged, PTEN forms a complex with another protein, p300, which in effect, switches on p53, a very important tumor suppressor.

“I would like to continue to expand our understanding of how p53 is activated in conjunction with PTEN and under what circumstances it functions to protect the cell,” Liu said.

Because her work has been done mostly in the test tube, Liu would like to determine whether her findings can be replicated in the animal testing phase.

Source: University of California, Riverside
 
Back
Top